GSA CAPITAL PARTNERS LLP - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$23,000
-92.2%
20,556
-87.2%
0.00%
-93.9%
Q1 2021$296,000
+51.8%
160,775
+80.5%
0.05%
+53.1%
Q4 2020$195,00089,0670.03%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 189,616$375,439,0001.17%
Ikarian Capital, LLC 1,365,059$2,703,0000.22%
Altium Capital Management LP 446,000$883,0000.20%
ASSET MANAGEMENT CORP /IL/ /ADV 91,500$181,0000.10%
Virtu Financial LLC 113,869$225,0000.02%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$20,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 155,069$307,0000.01%
McAdam, LLC 55,978$86,0000.01%
Moloney Securities Asset Management, LLC 27,340$54,0000.01%
Allen Capital Group, LLC 23,685$47,0000.01%
View complete list of HEPION PHARMACEUTICALS INC shareholders